GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | +100.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | -54.5% | 44 | -63.3% | 0.00% | -50.0% |
| Q1 2020 | $11,000 | -42.1% | 120 | -35.5% | 0.00% | -33.3% |
| Q4 2019 | $19,000 | -9.5% | 186 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $21,000 | -34.4% | 186 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $32,000 | +3.2% | 186 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $31,000 | +72.2% | 186 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $18,000 | -43.8% | 186 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $32,000 | +23.1% | 186 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $26,000 | +13.0% | 186 | -10.6% | 0.01% | +20.0% |
| Q1 2018 | $23,000 | +283.3% | 208 | +372.7% | 0.01% | +150.0% |
| Q4 2017 | $6,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |